Sotio as
Industry / private company
Location:
Prag,
Czech Republic (CZ)
ISNI: -
ROR: https://ror.org/027184q35
Show on Map:
Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial (2021)
Cibula D, Rob L, Mallmann P, Knapp P, Klat J, Chovanec J, Minar L, et al.
Journal article
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death (2015)
Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, et al.
Journal article